ACRV
Acrivon Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.69
+3.05%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-85.6%
Return on equity
-74.9%
Return on assets
-88.3%
Return on invested capital
0.00x
Asset turnover
-$62.9M
Cash from operations
$2.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026